Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR.
Latest News
Share this

REFLECT Clinical Update with TriGUARD3 Cerebral Embolic Protection Device

Tamim Nazif
  • TriGUARD 3 offers complete 3 vessel cerebral embolic protection for TAVR
  • Specific design improvements optimize safety, efficacy generalizability, and ease of use of cerebral protection
  • REFLECT Trial phase 2 is underway and expected to complete enrollment in early 2019
  • High rate of anatomic screening success based on CT Core Lab and Patient Review Committee (>90%)

Review the full presentation here:




No Comments

Leave a reply